アラスカ州における非小細胞肺癌の臨床試験
アラスカ州内の拠点で、非小細胞肺癌に関する11件の研究が参加者を募集しています。
アラスカ州内の都市
公式研究テキスト（英語）
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Fairbanks Memorial Hospital, Fairbanks
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- Alaska Oncology and Hematology, Anchorage
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07144280Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- Fairbanks Memorial Hospital, Fairbanks
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT03191149Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
- Research Site, Anchorage
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT06357533Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Alaska Oncology and Hematology, LLC, Anchorage
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06712316Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
- Alaska Oncology & Hematology, LLC, Anchorage
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06899126A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Alaska Oncology and Hematology, Anchorage
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06793215A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Alaska Oncology and Hematology, Anchorage
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Katmai Oncology Group, Anchorage
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Katmai Oncology Group, Anchorage
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Fairbanks Memorial Hospital, Fairbanks
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。